Name | (5R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
---|---|
Synonyms |
( )-Ganodermanondiol
Lanosta-7,9(11)-dien-3-one, 24,25-dihydroxy-, (24S)- Lanost-7,9(11)-dien-3-one-,24,25-dihydroxy-(24S) Lanosta-7,9(11)-dien-3-one,24,25-dihydroxy-,(24S) (24S)-24,25-Dihydroxylanosta-7,9(11)-dien-3-one Ganodermanondiol |
Description | Ganodermanondiol is a melanogenesis inhibitor isolated from the Ganoderma lucidum[1].Ganodermanondiol exhibits potent cytoprotective effects on tert-butyl hydroperoxide-induced hepatotoxicity[2]. Ganodermanondiol shows significant anti-HIV-1 protease activity with an IC50 of 90 μM[3]. Ganodermanondiol exhibits a strong anticomplement activity against the classical pathway of the complement system with an IC50 of 41.7μM[4]. |
---|---|
Related Catalog | |
Target |
IC50: 90μM (HIV-1 protease)[3] |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 580.4±50.0 °C at 760 mmHg |
Molecular Formula | C30H48O3 |
Molecular Weight | 456.700 |
Flash Point | 318.9±26.6 °C |
Exact Mass | 456.360352 |
PSA | 57.53000 |
LogP | 6.64 |
Vapour Pressure | 0.0±3.7 mmHg at 25°C |
Index of Refraction | 1.547 |
Hazard Codes | Xi |
---|
~% 107900-76-5 |
Literature: Ruzicka; Denss; Jeger Helvetica Chimica Acta, 1946 , vol. 29, p. 204,207 |
~% 107900-76-5 |
Literature: Ruzicka; Denss; Jeger Helvetica Chimica Acta, 1946 , vol. 29, p. 204,207 |